Zhejiang Hisun Pharmaceutical Co., Ltd. is publicly listed on the Shanghai Stock Exchange, trading under the official stock code 600267. Operating as a major comprehensive pharmaceutical enterprise engaged in the research, development, and manufacturing of synthetic drugs, biopharmaceuticals, and active pharmaceutical ingredients, its shares are actively traded on the mainland bourses.